GenDelph provides advanced systems for rapid annotation, dynamic variant classification, and personalized reports, facilitating high-impact genomic insights.
What do we offer?
Our Mission
At GenDelph, we are committed to democratizing access to high-precision genomic analysis while advancing the frontiers of precision medicine. We believe that personalized medicine based on genetic data should be accessible to everyone, and we endorse this mission with integrity and transparency. Through rigorous scientific practices and high standards of quality and security, we work to transform how genetic diagnoses are conducted, empowering geneticists and clinicians for better decision-making.
About Us
GenDelph was originated as an initiative at the Polytechnic University of Valencia, Spain, at the VRAIN Institute within the PROS research group. Today, our tool Delphi offers comprehensive genomic analysis services designed to support multiple pipelines for various diseases. Leveraging a proprietary, regularly updated database, Delphi provides clinicians and users with the flexibility to generate detailed genomic reports, significantly reducing the time required for this task while remaining more cost-effective than competitors.
Our hybrid team unites world-class academic researchers with technical professionals, creating a powerful synergy between genomic expertise and computational knowledge. Comprising bioinformaticians, molecular biologists, geneticists, software engineers, data scientists, and AI specialists from top research institutions, our interdisciplinary team collaborates closely to tackle complex genomic challenges from multiple perspectives. By bridging theoretical research with practical applications, we deliver valuable clinical tools that advance precision medicine.